Abstract
Mutations in the DNA damage repair (DDR) pathway are frequently detected in colorectal cancer (CRC). The dysregulation of miRNAs, such as oncogenes or tumor suppressors, participates in CRC tumorigenesis. A previous study showed that low miR-3607 expression correlated with poor survival in prostate cancer patients, but its role in CRC remains unclear. In this study, we analyzed miR-3607 expression Pan-Cancer data from the NCI’s Genomic Data Commons (GDC) and found that miR-3607 was downregulated in lymphatic invasion patients and in recurrent cancer and correlated with Pan-Cancer patient survival. Functional studies indicated that the overexpression of miR-3607 decreased CRC cell proliferation, migration and invasion. Additionally, we used gene set enrichment analysis (GSEA), Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and a protein–protein interaction network to demonstrate that miR-3607 affects the DDR pathway. Luciferase reporter and apoptosis assays confirmed that DNA damage inducible 1 homolog 2 (DDI2) is the functional target of miR-3607. Therefore, miR-3607 inhibits the tumorigenesis of CRC probably by suppressing the oncogene DDI2, and it might serve as a novel target for CRC prediction and therapy.
Similar content being viewed by others
References
Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS (2018) Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas. Cell Rep 23(1):239
Peltomäki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10(7):735–740
Jeggo PA, Pearl LH, Carr AM (2016) DNA repair, genome stability and cancer: a historical perspective. Nat Rev Cancer 16(1):35
Rich JN (2007) Cancer stem cells in radiation resistance. Can Res 67(19):8980–8984
Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Investig 119(6):1420–1428
Chandy C, Maitra R (2017) Emerging role of transcription factors in epithelial mesenchymal transition attributing to metastasis of colorectal cancer. of 7:2
Lee RC, Feinbaum RL, Ambros V (1993) The C elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843–854
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Tokarz P, Blasiak J (2012) The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochim Pol. https://doi.org/10.18388/abp.2012_2079
Saini S, Majid S, Shahryari V, Tabatabai ZL, Arora S, Yamamura S, Tanaka Y, Dahiya R, Deng G (2014) Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer. Mol Cancer Ther 13(7):1652–1693
Summy JM, Gallick GE (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22(4):337–358
Allgayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, Gallick GE (2002) Activation of Src kinase in primary colorectal carcinoma. Cancer 94(2):344–351
Su N, Peng L, Xia B, Zhao Y, Xu A, Wang J, Wang X, Jiang B (2012) Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer. Mol Cancer 11(1):43
Ishizawar R, Parsons SJ (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6(3):209–214
Chaudhry MA, Omaruddin RA, Brumbaugh CD, Tariq MA, Pourmand N (2013) Identification of radiation-induced microRNA transcriptome by next-generation massively parallel sequencing. J Rad Res 54(5):808–822
McDermott N, Meunier A, Wong S, Buchete V, Marignol L (2017) Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs. Clin Transl Radiat Oncol 2:63–68
Cuadrado M, Martinez-Pastor B, Murga M, Toledo LI, Gutierrez-Martinez P, Lopez E, Fernandez-Capetillo O (2006) ATM regulates ATR chromatin loading in response to DNA double-strand breaks. J Exp Med 203(2):297–303
Murga M, Jaco I, Fan Y, Soria R, Martinez-Pastor B, Cuadrado M, Yang S-M, Blasco MA, Skoultchi AI, Fernandez-Capetillo O (2007) Global chromatin compaction limits the strength of the DNA damage response. J Cell Biol 178(7):1101–1108
He H, Zhao X, Zhu Z, Du L, Chen E, Liu S, Li Q, Dong J, Yang J, Lei L (2019) MicroRNA-3191 promotes migration and invasion by downregulating TGFBR2 in colorectal cancer. J Biochem Mol Toxicol 4:4. https://doi.org/10.1002/jbt.22308
Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P (2016) The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucl Acids Res. https://doi.org/10.1093/nar/gkw937
Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial–mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172(7):973–981
Merlos-Suárez A, Barriga FM, Jung P, Iglesias M, Céspedes MV, Rossell D, Sevillano M, Hernando-Momblona X, da Silva-Diz V, Muñoz P (2011) The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8(5):511–524
Whitfield ML, George LK, Grant GD, Perou CM (2006) Common markers of proliferation. Nat Rev Cancer 6(2):99
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319(9):525–532
Halazonetis TD, Gorgoulis VG, Bartek J (2008) An oncogene-induced DNA damage model for cancer development. Science 319(5868):1352–1355
Tessitore A, Cicciarelli G, Del Vecchio F, Gaggiano A, Verzella D, Fischietti M, Vecchiotti D, Capece D, Zazzeroni F, Alesse E (2014) MicroRNAs in the DNA damage/repair network and cancer. Int J Genom. https://doi.org/10.1155/2014/820248
Wan G, Mathur R, Hu X, Zhang X, Lu X (2011) miRNA response to DNA damage. Trends Biochem Sci 36(9):478–484
Hu H, Gatti RA (2010) MicroRNAs: new players in the DNA damage response. J Mol Cell Biol 3(3):151–158
Kottemann MC, Conti BA, Lach FP, Smogorzewska A (2018) Removal of RTF2 from stalled replisomes promotes maintenance of genome integrity. Mol Cell 69(1):24–35
Longley DB, Latif T, Boyer J, Allen WL, Maxwell PJ, Johnston PG (2003) The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells. Semin Oncol 3:3–9
Chowdhury AMA, Katoh H, Hatanaka A, Iwanari H, Nakamura N, Hamakubo T, Natsume T, Waku T, Kobayashi A (2017) Multiple regulatory mechanisms of the biological function of NRF3 (NFE2L3) control cancer cell proliferation. Sci Rep 7(1):12494
Palma M, Lopez L, García M, de Roja N, Ruiz T, García J, Rosell E, Vela C, Rueda P, Rodriguez M-J (2012) Detection of collagen triple helix repeat containing-1 and nuclear factor (erythroid-derived 2)-like 3 in colorectal cancer. BMC Clin Pathol 12(1):2
LaPointe LC, Pedersen SK, Dunne R, Brown GS, Pimlott L, Gaur S, McEvoy A, Thomas M, Wattchow D, Molloy PL (2012) Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing. PLoS ONE 7(1):e29059
Acknowledgements
This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31401081) and the Natural Science Foundation of Shaanxi Provincial Department of Education (Grant No. 18JK0796).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
10495_2019_1549_MOESM1_ESM.tif
Fig. S1 Expression analysis of epithelial-mesenchymal transition (EMT) markers in CRC from the TCGA database using the TNM staging system. Expression data of EMT markers were normalized to fragments per kilobase of transcript per million mapped reads (FPKM) and are shown as log2(FPKM +1). All data are shown as the mean ± SEM, *P < 0.05 and **P < 0.01. Supplementary material 1 (TIFF 2116 kb)
Rights and permissions
About this article
Cite this article
Lei, L., Zhao, X., Liu, S. et al. MicroRNA-3607 inhibits the tumorigenesis of colorectal cancer by targeting DDI2 and regulating the DNA damage repair pathway. Apoptosis 24, 662–672 (2019). https://doi.org/10.1007/s10495-019-01549-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-019-01549-5